Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Breakthrough Influenza Treatment To Be Available

Breakthrough Influenza Treatment To Be Available This Winter



New Zealand influenza sufferers now have access to a breakthrough product for the treatment of influenza, Relenza (Zanamavir). Glaxo Wellcome NZ managing director Steve Skolsky says approval and registration processes have just been completed for the product, which will be available as a prescription medicine from 1 July.

Mr Skolsky says interest in the new product has been high because of the current influenza epidemic. "There has been considerable anticipation for Relenza because it finally offers a treatment for the causes of influenza where, in the past, there have been no effective options."

Key points


1. Relenza is administered using an oral inhaler and is a prescription-only medicine. Influenza is a viral infection of the lungs, and administering Relenza by inhalationensures it gets straight to the site of infection, with minimal side effects.

2. Relenza should be used within 48 hours of developing influenza.

3. Clinical trials in Australia, New Zealand and South Africa showed that patients with influenza treated with Relenza experienced a significant reduction in the severity of their symptoms (see references in attached detailed release).Note: Patients suffering from influenza-like symptoms should consult with their general practitioner at the onset of symptoms.

4. The cost to patients of a five-day treatment will be approximately $60-70. Relenza has not received government funding.

5. Relenza was invented in Australia in the 1990s by Glaxo Wellcome and Australian company, Biota Holdings.

(Continues - see next release)

© Scoop Media

Business Headlines | Sci-Tech Headlines


Manawatu-Whanganui Projects: PGF Top-Up To Rural Broadband Roll-Out

The government has effectively raided the $3 billion Provincial Growth Fund to top up the budget for the second phase of its rural broadband initiative, filling in mobile 'black spots' and ensuring broadband is available to marae that don't have access now. More>>


Other Windy Cities: Auckland-Chicago Named A Top 10 ‘Most Exciting’ New Route

The inclusion of Auckland-Chicago on Lonely Planet’s Where to fly in 2019? The 10 most exciting new flight routes list comes just two weeks before Air New Zealand prepares to celebrate its inaugural flight to Chicago’s O’Hare International Airport on 30 November. More>>

Deadly Strain: ESR Ups Its Reporting On Meningococcal Disease

The increasing number of cases of Group W Meningococcal disease (MenW) has prompted ESR to increase its reporting on the disease to the Ministry of Health. ESR has upped its reporting to weekly. More>>


Very Small Things: "Game-Changing" 3D Printing Technology Launched

New Zealand microfabrication researchers Andrea Bubendorfer and Andrew Best, the co-inventors of a new way of fabricating very small things with Laminated Resin Printing (LRP), are part of Callaghan Innovation’s MicroMaker3D team launching the new patent pending technology in the US this week. More>>